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The purpose of this work is to determine appropriate radiation therapy beam margins to account for intrafraction prostate
translations for use with real-time electromagnetic position monitoring and correction strategies. Motion was measured
continuously in 35 patients over 1157 fractions at 5 institutions. This data was studied using van Herk’s formula of (αΣ + γσ )
for situations ranging from no electromagnetic guidance to automated real-time corrections. Without electromagnetic guidance,
margins of over 10mm are necessary to ensure 95% dosimetric coverage while automated electromagnetic guidance allows the
margins necessary for intrafraction translations to be reduced to submillimeter levels. Factors such as prostate deformation
and rotation, which are not included in this analysis, will become the dominant concerns as margins are reduced. Continuous
electromagnetic monitoring and automated correction have the potential to reduce prostate margins to 2-3mm, while ensuring
that a higher percentage of patients (99% versus 90%) receive a greater percentage (99% versus 95%) of the prescription dose.
1.Introduction
The goal of conformal radiation therapy is to shape the dose
distributiontotheprescribed targetvolumeascloselyaspos-
sible without sacriﬁcing target coverage. This technique
resultsinthesparing ofneighboringhealthytissues andoften
leadsto fewercomplicationsand higher qualityoflife. Itmay
also allow higher doses to target volumes that are limited by
toxicity of normal tissues, potentially resulting in better local
tumorcontrol.In thelast ﬁveyears, real-time electromagnet-
ictrackingoftheprostatehas becomecommerciallyavailable
and has been adopted as the preferred localization technique
in many clinics where it is available. The technology makes
it possible to essentially eliminate interfraction variations,
greatly reduces systematic uncertainties, and allows intra-
fraction target volumemotionto bemonitored continuously
throughout treatment so that corrective adaptive action may
be taken.
A description of the Calypso System has been previously
reported [1, 2]. Brieﬂy, the system consists of a tracking sta-
tion (placed in the control room) to display real-time devia-
tions for the target volume from isocenter. Ceiling-mounted2 Prostate Cancer
infrared cameras localize an electromagnetic array which is
placed over the patient before and during treatment. The
array excites and localizes transponders which are implanted
transrectally into the prostate. The transponders are 8mm
long by 1.85mm in diameter and are implanted transrectally
witha14gaugeneedleusingsimilarproceduresforobtaining
prostate biopsies. Transponders were placed at the apex and
right- and left-base under ultrasound guidance. An isocenter
was chosen relative to the geometric center of the transpon-
ders on CT, and the (supine) patients were positioned to
this isocenter using the electromagnetic system. The relative
stability of the transponders within the prostate has been
previously reported to have a standard deviation of 0.9 to
1.2mm about their expected separations over the course of
therapy [3]. The measurement uncertainties associated with
this device are <0.54mm in all directions for transponders
at the far boundary (27cm from the array), of the 14cm ×
14cm × 27cm active tracking volume, and for transponder
velocities up to 3.0cm/s [1].
Usingthetranspondersassurrogatesforprostatemotion,
the distribution ofdeviations from isocenter has been shown
to vary widely from patient to patient and from fraction
to fraction. For 20 patients, deviations >3mm occurred
13.6% of the time on average, though individual patients
exhibited deviations >3mm for as much as 36.2% of the
time over the course of their therapy. While some patients
are extremely stable on any given fraction, at other times
or in other patients, deviations >3mm occurred 98.7% of
the time [4]. Based on limited initial data, margins were
estimated from a data set where prostate motion was tracked
continuously in 11 patients for 8–10 minutes each [5]. (To
simulate a treatment fraction, each of the patients were setup
in a treatment room in a clinical supine treatment position,
thoughnotreatment wasdelivered.)Margin estimates varied
dependingon the amount of correctiveaction taken,ranging
from approximately 7mm for single daily pretreatment po-
sitioning, to 1.5mm when positioning was corrected to iso-
center when a 3mm action threshold was exceeded.
A multi-institutional clinical study has since been con-
ducted[6] in which electromagnetic guidance was used daily
on over 40 patients who were enrolled in IRB-approved pro-
tocols. Continuous tracking during therapy was conducted
in 35 patients. In the study presented here, the PTV margins
required to account for intra-fraction target volume motion,
for a variety of real-time correction strategies, are studied
usingdatafromreal-time (∼10Hz)electromagnetic tracking
with the Calypso System (Calypso Medical, Seattle, Wash,
USA), based on this much larger multi-institutional clinical
dataset. At the time thisstudy was conducted,the system was
an investigational device but has since received FDA 510(k)
clearance and is now commercially available.
2.Materialsand Methods
Under IRB-approved protocols, 35 patients at 5 institutions
were continuously tracked during treatment to study intra-
fractionprostatemotionusingtheCalypsoSysteminwhich 3
Beacon electromagnetic transponders are implanted into the
prostate. The prostate was initially aligned using skin marks
and lasers. The Calypso System was then used to localize the
prostate based on predetermined transponder positions re-
lative to isocenter on the treatment planning CT. The devia-
tions of the prostate from isocenter were measured continu-
ously (10Hz) during 1157 fractions.
2.1. Analysis. This data was studied,using the method ofvan
Herk [7, 8] to determine appropriate clinical target volume
(CTV) to planning target volume (PTV) margins under var-
ious conditions. By this methodology, CTV to PTV margins,
m,a r eg i v e nb y
m = αΣ+ γσ
 ,( 1 )
where α and γ specify the conﬁdence level in determining
the margins due to systematic and random errors, and Σ = 
Σ2
s,Inter+Σ2
Intra and σ  =

σ2
s,Inter+ σ2
Intra, are respectively,
the standard deviation of all appropriate preparation (sys-
tematic) and treatment (random) errors for a population of
patients, added in quadrature. (In this methodology, prepa-
ration errors are deﬁned as those that lead to a displacement
of the dose distribution with respect to the CTV while
treatment errors lead to a blurring of the dose distribution.)
The subscripts, “s,” “Inter,” and “Intra,” denote setup, inter-
fraction motion, and intra-fraction motion, respectively.
The systematic errors associated with initial patient setup
and inter-fraction variation of internal anatomy are given
by Σs,Inter while ΣIntra is the systematic error associated
with average daily changes during treatment. Likewise, the
random errors associated with initial patientsetup and inter-
fraction variation of internal anatomy are given by σs,Inter
while σIntra is the random error associated with average daily
changes during treatment.
Commonly used values of α = 2.5a n dγ = 0.7w e r eu s e d
to estimate margins, m90,95, where 90% of patients would
r e c e i v eam i n i m u md o s eo f9 5 %o ft h ep r e s c r i p t i o nd o s e .I n
addition, values of α = 3.36 and γ = 0.95 were also used
to estimate margins, m99,99, where 99% of patients would
receive a minimum dose of 99% of the prescription dose.
Margins were estimated for situations of skin-based posi-
tioning (a) with and (b) without inclusion of intra-fraction
(IF) motion, (c) prefraction transponder positioning with
(i) no further correction and corrective action levels (AL) at
(ii) 5 and (iii) 3mm deviations, and (d) prebeam correction
with correction strategies (i)–(iii). Analysis for (c): (i) is ﬁrst
conducted using all available motion data measured during
each fraction, then again using only motion data when the
radiation beam was on. The remainder of the analysis in
(c), (ii)-(iii) and (d), (i)–(iii) was performed using only
motion data collected while the radiation beam was on.
Intratreatment intervention and correction for all excessive
motion were simulated as radiation beam gating when a
trackinglimit wasexceeded,followed byposition adjustment
and immediate resumption of treatment. Repositioning
accuracy was simulated using a Gaussian distribution about
the planned position with a standard deviation of 0.5mm as
measured with a phantom.Prostate Cancer 3
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Figure 1: Successive table shifts toward isocenter were present in
8.2% of the measured fraction, such as thoseseen here in the IS and
AP directions. Table shifts were removed to reduce the bias toward
isocenter in measured prostate displacements.
2.2. Removal of Intrafraction Realignments. As previously
discussed, [6] each institution in the study developed its
own guidelines on how to adapt treatment when motion
occurred during radiation delivery. These ranged from
purely observational with no corrective action to stopping
the radiation beam and moving the treatment couch to
correct persistent deviations from isocenter. Because couch
adjustments were used to realign the target volume back
to isocenter in 8.2% of all fractions, a bias toward smaller
deviations was introduced into the raw data. The recorded
realignments were apparent in the raw tracking data as
sequential shifts to isocenter in each direction. To reduce this
bias for the purposes of this study, these realignments were
programmatically removed in a semiautomated manner.
The slope and standard deviation of the data prior to the
realignment were estimated, and the times at which the
realignment were initiated and ﬁnished were noted. During
the time of the realignment, the trajectory was simulated to
have the same slope and standard deviation as that prior
to the realignment. The raw data after the realignment was
completed were oﬀset to be continuous with the end of the
simulated data, as shown in Figure 1.
2.3. Margins for Skin-Based Setup with and without Intrafrac-
tion Motion. After the target volume is positioned using
skin marks, the residual setup error is removed using
electromagnetic alignmenttothetransponders, suchthatthe
system reads 0.0 ± 0.5mm. This residual setup error is used
to determine the appropriate PTV margins for setup based
on skin marks without inclusion of intra-fraction motion.
To include the inﬂuence of intra-fraction motion in the
margins, these residual setup error values were used to oﬀset
the continuously measured intra-fraction motion data to
their uncorrected initial positions.
2.4. Margins for Pretreatment Setup to Implanted Transpon-
ders. In the multi-institutional study, each institution devel-
oped their own protocol for use of the system, and in many
treatment fractions, comparisons to orthogonal diagnostic
X-ray imaging were performed after alignment to the trans-
ponders and before the beginning of treatment [6]. Collec-
tion of the X-ray images typically took approximately 2–5
minutes, allowing time for the target volume to move from
the baseline position. Generally, if deviations were present
after X-ray veriﬁcation, each institution would realign the
targetvolumeusing thetransponders beforebeginning treat-
ment per the tolerance allowed by their protocol, with treat-
ment beginning 1-2 minutes thereafter. Again, deviations
from isocenter due to motion may occur during this slight
delay. The mean and standard deviation of initial positions
in the left-right (LR), superior-inferior (SI), and anterior-
posterior (AP) directions were LR =− 0.05 ± 0.43mm,
SI = 0.03 ± 0.80mm, and AP =− 0.11 ± 0.76mm with
ranges of LR = [−3.7,1.2]mm, SI = [−7.9,9.2]mm, and
AP = [−4.6,8.3]mm.
In estimating the necessary treatment margins when the
target volume is setup to the transponders before each frac-
tion, the preparation and treatment errors due to skin mark
setup and inter-fraction motion are assumed to be zero
in (1). In addition, intra-fraction motion preparation and
treatment errors are ﬁrst calculated using all the tracking
data measured during each treatment fraction, and secondly,
including only motion data when the radiation beams were
on.
2.5. Margins for Pretreatment Setup to Implanted Transpon-
ders with Action Thresholds. Among the protocols imple-
mented during the study, action levels of 3 and 5mm
were established at some institutions. In these cases, the
radiation beamwas manually gated ordelayeduntil theposi-
tional discrepancy was resolved to within tolerance. Some
deviations from isocenter were transient excursions that
resolvedthemselves,typicallywithin 20seconds,while others
were drifts that were corrected by couch translations. The
frequency of deviations exceeding these action thresholds
has previously been reported [6] to be 41% of fractions
and 100% of patients for deviations >3mm, and 15% of
fractions and 83% of patients for deviations >5mm, with
large variations among patientsand fromfraction to fraction
for any given patient.
The corrective actions implemented in this study may
takefromfew minutestofew seconds,dependingonthelevel
of automation implemented in the institutions repositioning
system. Consequently, when the average position over the
last second (10 data points in this case) exceeded an action
threshold, the remaining data was simply oﬀset back to
isocenter in all directions from that time forward, and the
treatment resumed immediately. For calculations in this
and following sections, the remote corrections made by the
treatment couch had a Gaussian repositioning accuracy of
σ = 0.5mmineachdirection.
2.6. Margins for Prebeam Setup to Implanted Transponders.
Because many patients exhibit some drift in the position of
the target volume over the course of a single fraction, the
preparation and treatment errors over the course of a typical
treatment fraction may be signiﬁcantly larger than that over4 Prostate Cancer
the course of delivery of a single radiation beam. Conse-
quently, smaller margins are expected if the target volume is
repositioned before each radiation beam is initiated. To
achieve this frequency of corrective intervention, the couch
shifts are made remotely using the machine control interface
bythetherapistsfromoutsidethetreatment roomso thatthe
next radiation beam is started immediately thereafter.
Radiation beam on and oﬀ times were recorded during
the study for the patients considered here. The times were
recorded manually by observers and considered to be accu-
rate within about 5 seconds. The preparation and treatment
errors for all radiation beams of all patients are added in
quadrature to determine population margins for prebeam
repositioning.
2.7. Margins for Prebeam Setup to Implanted Transponders
with Action Thresholds. In these simulations, the target vol-
ume was repositioned at the beginning of each radiation
beam and corrected back to isocenter if an action threshold
was exceeded as previously described. From a calculation
perspective, it is again assumed that threshold violation
corrections take no time. (No position data was skipped for
purposes ofthisanalysis toaccount formotion thatoccurred
when the radiation beam would have otherwise been oﬀ
during position corrections.) Again, the preparation and
treatment errors during the treatment periods are added in
quadrature to estimate appropriate population margins for
prebeam setup to implanted markers with action threshold
of 3 and 5mm along each axis.
3.Results
T h er e s u l t sa r es h o w ni nFigure 2. Positioning by skin marks
alone, and ignoring intra-fraction motion, (a), requires mar-
gins of (LR,SI,AP)90,95 = (13.2,8.2,14.8)mm while inclu-
sion of intra-fraction motion, (b), increases margins to
(LR,SI,AP)90,95 = (14.7,10.3,15.9)mm. Prefraction posi-
tioning, (c), using all data gives margins of (LR,SI,AP) =
(1.1,2.5,2.3)mm while correction strategies for (i) no
further intervention, (ii) correction to isocenter with a 5mm
action threshold, and (iii) 3mm action threshold, using only
motion data measured when the radiation beam was on,
results in margins of (2.4, 4.8, 4.7)mm, (1.1, 2.1, 2.2)mm,
and (1.0, 1.4, 1.5)mm, respectively. Prebeam positioning,
(d), plus correction strategies (i)–(iii) result in margins of
(0.4, 0.6, 0.7)mm, (0.4, 0.6, 0.6)mm, and (0.4, 0.6, 0.5)mm,
respectively.
Using values of α = 3.36 and γ = 0.95 in (1), such
that 99% of patients receive a minimum dose of 99% of
the prescription dose for strategies (c): (i)–(iii), results in
margins of m99,99 = (LR,SI,AP)99,99 = (1.6,3.8,3.6)mm,
(1.5, 2.9, 2.9)mm, and (1.4, 1.9, 2.0)mm, respectively.
Prebeam positioning, (d), plus correction strategies (i)–(iii)
result in margins of m99,99 = (LR,SI,AP)99,99 = (0.6,0.8,
0.9)mm, (0.6, 0.8, 0.8)mm, and (0.6, 0.8, 0.7) mm, respec-
tively. These results are shown in Figure 2,w i t hm90,95 for
comparison.
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Figure 2: PTV marginsforreal-timecorrection strategies forwhich
90% or 99% of patients receive a minimum dose greater than 95%
or 99% of the prescription dose, respectively. Margins based on
(c) prefraction, (d) prebeam correction (i) alone, or with further
correction at thresholds of (ii) 5mm and (iii) 3mm are shown.
Margins decrease with increased levels of corrective action.
4.Discussion
The results presented here were determined from 1157 treat-
ment fractions delivered to 35 patients at 5 institutions.
Previous preliminary results were estimated from 11 sim-
ulated treatment fractions, each from 11 diﬀerent patients
[5]. Margins for setup to skin marks found here, (LR,SI,
AP)90,95 = (13.2, 8.2, 14.8)mm, are signiﬁcantly larger than
those reported in the previous work, (LR,SI,AP)90,95 =
(8.0,10.0,7.3)mm. Additionally, the LR and AP margins
are signiﬁcantly larger than the 10mm margins commonly
used at many institutions. This is largely attributed to the
variation among protocols at the 5 institutions which may
or may not have placed special emphasis on alignment to
skin marks, knowing that the target volume position would
subsequently be corrected to isocenter using transponders.
Including the intra-fraction data with the skin-based setup
increased margins by 1.1mm to 2.1mm, which is slightly
smaller than the 2-3mm increase found in the previous
study.
In the simplest correction scenario, (c): (i), the target
volume is aligned once prior to treatment, similar to the
correction strategy used for gold marker implants. Align-
ment to transponders resulted in margins of (LR,SI,AP) =
(1.9,4.1,3.9)mm when all the motion data is used. Because
thereisadelayof1-2minutesbeforetheﬁrst,andsubsequent
r a d i a t i o nb e a m sa r et u r n e do n ,t h e r ei st i m ef o rt h ep r o s t a t e
to move away from isocenter. Consequently, only using the
intra-fraction motiondata, when theradiation beamwas on,
results in margins that are slightly larger, 0.5mm, in the IS
and AP directions. While this is not large, it demonstrates
that delays between determining ﬁducial oﬀsets, making
corrections, and beginning treatment lead to larger marginsProstate Cancer 5
and should be minimized. It should also be noted that these
margins are 2-3mm smaller than previously found from
preliminary data [5]. This is attributed to the small number
of simulated fractions (eleven) previously available and the
relatively large variation that was seen among the eleven
subjects.
Strategies thatimplement action levelsof3mm or5mm,
for interventional correction during treatment, (c): (ii)-(iii),
allow margins that are 1-2mm smaller than strategy, (c):
(i), where only prefraction alignment was used. This strategy
was used at two of the ﬁve institutions who participated in
this study, with 3mm and 5mm action levels, and is used
at the University of Michigan with a 3mm action level. In
this strategy, the therapist manually gates the radiation beam
when deviationsexceed the action level. While this allows for
smaller margins, it can increase the time the patient is on
the treatment table. It has been reported that, for patients
in this study, 77% and 88% of excursions from isocenter
resolve themselves within 15 seconds and 30 seconds,
respectively[9].Consequently,alargemajorityofcorrections
areresolvedin<15–30secondswithoutthetherapistneeding
to enter the treatment room which would nominally take
2-3 minutes before resuming treatment. Interfacing of elec-
tromagnetic tracking technology with treatment machine
control features, such as radiation beam gating and adaptive
couch repositioning to correct misalignments between the
prostate and radiation beam, will allow these corrections to
be made in a more automated fashion and very quickly. It
would be possible to make corrections to isocenter before
eachradiationbeamisturnedonandwhendeviationsexceed
pre-deﬁned action levels. In these cases, scenarios (d): (i)–
(iii), the margins to account for intra-fraction motion may
be roughly 2mm or less. It should be noted that the results
presented here generally agree with those of Tanyi et al. [10],
whofoundthatmarginsof1.36to2.64mmwereneededwith
Calypso-based alignment.
In a recent study, Li et al. [11] used the same multi-
institutional prostate motion data used here in a dosimetric
study to ﬁnd appropriate PTV margins. In that study, the
probability density function (PDF) for each fraction of each
of the 35 patients was determined. These were convolved
with the static dose distributions of two prostate cases from
patients not in the study in order to estimate the dosimetric
impact of intra-fraction motion. The correction scenarios
simulated in that study were similar to scenarios, (c): (i)–
(iii), here, prefraction alignment with no further corrections
a n dc o r r e c t i o n sb a s e do n3a n d5m mt h r e s h o l d s .I na l lt h r e e
scenarios, they found that a 2mm margin was adequate to
maintain a minimum CTV (prostate gland) dose >95% of
the prescription dose in all motion applied to both cases.
While this is consistent with the LR population margins
found here, it is 0.5mm to 2mm smaller than the PTV
margins found in the IS and AP directions in this study. It
should be reiterated here that the formalism of van Herk,
used in this study to determine margins, was also designed
to achieve a minimum dose to the CTV of >95% of the pre-
scribed dose, in 90% of patients. As reported by Gordon and
Siebers [12], margins found in dosimetric studies, such as
those by Li et al. [11], may be smaller than those found with
the van Herk margin formula, due to the perfect PTV-to-
CTVconformationassumedinthederivationoftheformula.
While the study by Li et al. used seven uniformly distributed
axial radiation beams to achieve a highly conformal IMRT
plan, the conformality index of those plans was not reported
a n dm u s tb ea s s u m e dt ob el e s st h a np e r f e c t .
It should also be noted that prostate rotations were not
included here or in the study by Li et al. Other studies have
found that the dosimetric impact of prostate rotations is
small when 5–10mm margins are used [13, 14]. However, as
margins become smaller, the impact of rotations is expected
to become more important. Another study by Rijkhorst et al.
showed that when rotationswere notcorrected insimulation
studies, the necessary margin increased from 4mm to 6mm
to achieve a minimum dose to the CTV >95% of the
prescribed dose, in at least 90% of patients [15].
Severalyears ofexperiencewith electromagnetic tracking
indicates that the system calibration is quite stable over time,
though this has not been quantiﬁed. However, a factor that
limits the accuracy that may realistically be achieved with
the electromagnetic tracking system used in this study is
its calibration to isocenter using the room lasers. While
lasers are typically checked daily with a 2mm tolerance, it
is likely that they are adjusted to isocenter less frequently,
typically monthly, with some small error, perhaps with an
accuracy of 0.5mm. This would lead to a small systematic
error in tracking system calibration that would likely change
direction and magnitude, once or twice during a prostate
patient treatment, which typically lasts 8 weeks. Because
margins are sensitive to systematic errors, whose standard
deviations are added in quadrature, small errors in system
calibration will become more important for margins below
a few millimeters. Obviously, great care should be taken to
calibrate thelasers as accurately as possible before calibrating
the tracking system.
Consequently,the margins calculatedhere only represent
thosewhich areneededtoaccountforintrafractional transla-
tional motion using the various intervention scenarios stud-
ied. The sub-millimeter results, shown in Figure 2, suggest
that as electromagnetic guidance becomes more integrated
loss of dosimetric coverage due to translations will become
very small compared tootheruncertainties. In particular, the
accuracy of the system relative to radiation isocenter must
be studied in greater detail, and the impact of deformations
and rotations on dosimetric coverage must be further
investigated. Due to other uncertainties mentioned above,
margins below 5mm should only be used with great care to
monitor and minimize their eﬀects.
Finally, electromagnetic tracking oﬀers the opportunity
to pursue greater consistency in outcomes by seeking to de-
liver a minimum dose to the CTV, which is a higher per-
centage of the prescription dose, to a higher percentage of
patients. Because the systematic and random errors in deter-
mining the position of the target volume can be greatly
reduced through increasing levels of real-time correction, it
becomespossible to choose parameters for the margin recipe
such that 99% of patients receive a minimum dose of 99% of
the prescription dose, while using margins that are smaller
than the 5 to 10mm margins commonly used today.6 Prostate Cancer
5.Conclusions
The ability to continuously monitor intra-fraction prostate
motion has a signiﬁcant impact on the population margins
required for prostate treatment. Increasing degrees of correc-
tiveinterventionhavethepotentialtoreducePTVmargins to
approximately 2mm while simultaneously allowing a larger
percentage of patients (99% versus 90%) to receive a min-
imumdosewhichisahigherpercentage(99%versus95%)of
the prescription dose. Reducedmotion and margins result in
less dose to healthy surrounding tissue and higher minimum
dose to the intended target, which may lead to fewer compli-
cations and improved control rates.
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